Pegram

623 total citations
2 papers, 507 citations indexed

About

Pegram is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Pegram has authored 2 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Pulmonary and Respiratory Medicine and 1 paper in Genetics. Recurrent topics in Pegram's work include HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (1 paper) and Lung Cancer Treatments and Mutations (1 paper). Pegram is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (1 paper) and Lung Cancer Treatments and Mutations (1 paper). Pegram collaborates with scholars based in United States. Pegram's co-authors include Richard J. Pietras, Liliana Ramos, Jane Arboleda, Slamon Dj and Rebecca Lee and has published in prestigious journals such as Breast Cancer Targets and Therapy and PubMed.

In The Last Decade

Pegram

2 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pegram United States 2 355 230 220 140 98 2 507
P. Cannon United Kingdom 7 294 0.8× 183 0.8× 181 0.8× 60 0.4× 123 1.3× 10 496
Indira Poola United States 12 210 0.6× 182 0.8× 278 1.3× 40 0.3× 150 1.5× 15 490
Jacqueline C. Newby United Kingdom 4 276 0.8× 213 0.9× 198 0.9× 81 0.6× 134 1.4× 5 434
Christina M.W. Chan United Kingdom 9 160 0.5× 259 1.1× 256 1.2× 73 0.5× 83 0.8× 12 463
Carol M. Dutkowski United Kingdom 9 287 0.8× 188 0.8× 329 1.5× 33 0.2× 86 0.9× 14 544
J M Knowlden United Kingdom 6 367 1.0× 127 0.6× 311 1.4× 113 0.8× 100 1.0× 6 574
Mariko Nishio Japan 10 394 1.1× 208 0.9× 272 1.2× 47 0.3× 240 2.4× 12 621
Annabell S. Oh United States 12 277 0.8× 325 1.4× 395 1.8× 35 0.3× 118 1.2× 13 615
Charlotte Andrieu France 8 178 0.5× 116 0.5× 207 0.9× 28 0.2× 154 1.6× 12 441
M Dowsett United Kingdom 9 277 0.8× 321 1.4× 239 1.1× 25 0.2× 165 1.7× 11 515

Countries citing papers authored by Pegram

Since Specialization
Citations

This map shows the geographic impact of Pegram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pegram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pegram more than expected).

Fields of papers citing papers by Pegram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pegram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pegram. The network helps show where Pegram may publish in the future.

Co-authorship network of co-authors of Pegram

This figure shows the co-authorship network connecting the top 25 collaborators of Pegram. A scholar is included among the top collaborators of Pegram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pegram. Pegram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Lee, Rebecca, et al.. (2010). Lapatinib: new opportunities for management of breast cancer. Breast Cancer Targets and Therapy. 2. 79–79. 14 indexed citations
2.
Pietras, Richard J., et al.. (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.. PubMed. 10(12). 2435–46. 493 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026